Dergiler / Turkish Journal of Biology / 2020 / Cilt: 44 - Sayı: SI-1

An updated analysis of variations in SARS-CoV-2 genome

Sayfa
157–167
Yayın Tarihi
2020-06-21
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

All these data should be considered towards development of vaccine and antiviral treatment strategies as well as tracing diversity of virus in all over the world.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:A novel pathogen, named SARS-CoV-2, has caused an unprecedented worldwide pandemic in the first half of 2020.
📊
Temel Bulgular & Veri:As the SARS-CoV-2 genome sequences have become available, one of the important focus of scientists has become tracking variations in the viral genome.
💡
Sonuç & Katkı:All these data should be considered towards development of vaccine and antiviral treatment strategies as well as tracing diversity of virus in all over the world.
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:SARS-CoV-2 · COVID-19 · genomic diversity

Abstract

A novel pathogen, named SARS-CoV-2, has caused an unprecedented worldwide pandemic in the first half of 2020. As the SARS-CoV-2 genome sequences have become available, one of the important focus of scientists has become tracking variations in the viral genome. In this study, 30366 SARS-CoV-2 isolate genomes were aligned using the software developed by our group (ODOTool) and 11 variations in SARS-CoV-2 genome over 10% of whole isolates were discussed. Results indicated that, frequency rates of these 11 variations change between 3.56%-88.44 % and these rates differ greatly depending on the continents they have been reported. Despite some variations being in low frequency rate in some continents, C14408T and A23403G variations on Nsp12 and S protein, respectively, observed to be the most prominent variations all over the world, in general, and both cause missense mutations. It is also notable that most of isolates carry C14408T and A23403 variations simultaneously and also nearly all isolates carrying the G25563T variation on ORF3a, also carry C14408T and A23403 variations, although their location distributions are not similar. All these data should be considered towards development of vaccine and antiviral treatment strategies as well as tracing diversity of virus in all over the world.

🔖

Bu Makaleye Atıf Yap

UGUREL, O. M., ATA, O., TURGUT-BALİK, D. (2020). An updated analysis of variations in SARS-CoV-2 genome. Turkish Journal of Biology, Cilt: 44 - Sayı: SI-1, 157–167. https://ajindex.com/articles/204381

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Angelini MM, 2013,
  2. MBIO, V4, DOI 10.1128/mBio.00524-13 Azhar EI, 2014, NEW ENGL J MED, V370, P2499, DOI 10.1056/NEJMoa1401505 Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293 Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642 Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1 Briguglio I, 2011, INT J MED CHEM, V2011, DOI 10.1155/2011/213135 BULMER M, 1987,
  3. NATURE, V325, P728, DOI 10.1038/325728a0 CARNEIRO JS, 1995, J GEN VIROL, V76, P1189, DOI 10.1099/0022-1317-76-5-1189 Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681 Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07 Chew Suok Kai, 2007, Bull World Health Organ, V85, P324 Cock PJA, 2009,
  4. BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163 Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9 de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13 De Lorenzo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166719 de-Dios T, 2020, INFECT GENET EVOL, V80, DOI 10.1016/j.meegid.2020.104209 DUNCAN BK, 1980,
  5. NATURE, V287, P560, DOI 10.1038/287560a0 Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018 Fang SG, 2007,
  6. VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020 Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147 Gadlage MJ, 2008, J VIROL, V82, P11964, DOI 10.1128/JVI.01126-07 Gallagher TM, 2001,
  7. VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757 Ge XY, 2013,
  8. NATURE, V503, P535, DOI 10.1038/nature12711 Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017 Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005 Guan Y, 2003,
  9. SCIENCE, V302, P276, DOI 10.1126/science.1087139 Hadfield J, 2018,
  10. BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407 Issa E, 2020,
  11. MSYSTEMS, V5, DOI 10.1128/mSystems.00266-20 Jang KJ, 2008, BIOCHEM BIOPH RES CO, V366, P738, DOI 10.1016/j.bbrc.2007.12.020 Kang SS, 2020, ACTA PHARMACOL SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009 Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108 KIMURA M, 1977,
  12. NATURE, V267, P275, DOI 10.1038/267275a0 Kiyotani K, 2020, J HUM GENET, V65, P569, DOI 10.1038/s10038-020-0771-5 Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219 Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389 Kwong AD, 2005, NAT REV DRUG DISCOV,